Clinical Trial Update: Cetuximab in Combination With Anti-PD-1 and mFOLFOX Treat For RAS/BRAF wt Right-Sided Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on cetuximab combined with anti-PD-1 and mFOLFOX for RAS/BRAF wild-type right-sided colon cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colonic Neoplasms
• Colorectal Cancer

Drugs mentioned

• Anti-PD-1
• Cetuximab (cetuximab)
• mFOLFOX

Snippet

Sponsor: Tongji Hospital | Conditions: Colonic Neoplasms | Phase 2 | Status: UNKNOWN